OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-6210717
  • Global Computational Biology Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: July 2017 | Report Code: HHE-6210717

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Computational biology is the branch of science which uses biological to develop models or algorithms to understand the various biological systems and relationships. It provides many advantages related to aspects of bioinformatics such as reduction of chances for humans to intake test drugs in the development phase, flexibility to use computation biology technology, provides high data accuracy etc. Due to several advantages offered by computational biology, it has got wide number of applications in academics, industrial and commercial sectors. Thus, its applications are boosting the global computational biology market with a CAGR of around 21% during the forecast period 2016-2023. As per Sanofi, there has been recent advances in the biological science which are leading to the modification of existing methodologies due to which biological and pharmaceutical issues are being addressed.

The key factor responsible for driving the growth of global computational biology market is the increasing adoption of computational biology technology. It facilitates the ideas to be transformed into hypotheses. Usage of statistics and data analytics in computational biology have reshaped biology.  Computational biologists often use the computational biology techniques to figure out the answer to the questions of biological and biomedical fields in order to produce highly accurate data in order to enhance the productivity and efficiency of computational biology and analysis. Large amount of biological data has been generated from next-generation sequencing, mass spectrometry, microarrays, cryo-electron microscopy, and other high-throughput approaches. This led to increased adoption of computational biology technology in order to obtain new insights of genetic infectious diseases, basic biology, cancer and human migration patterns.

Source: OBRC Analysis.

The report on global computational biology market includes tools, services applications and end users.

Tools included in computational biology market report are:

  • Databases
  • Infrastructure (Hardware)
  • Analysis software &services




 

Services included in computational biology market report are:

  • In-house computational biology
  • External/Contract computational biology



 

The applications of computational biology include:

  • Cellular &biological simulation
  • Drug discovery and disease modelling
  • Preclinical drug development
  • Clinical trials
  • Human body simulation software






 

The end users of computational biology include:

  • Academics
  • Industrial
  • Commercial




 

The global computational biology market report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





 

North America has emerged as the largest market for computational biology market. The region had accounted for global share of about 58% in terms of revenue share in2015. The key factors contributing the growth of market in North America are growing initiatives and investments for research and development of drug discovery, technologies of disease modeling and modernization in the existing biological computation methods. For instance; In April 2017, Merck joined Drug discovery booster consortium of DND to initiate new treatments for deserted diseases. Asia pacific is the fastest growing computational biology market region and is anticipated to grow with a CAGR of around 29% during the forecast period. The key reason for this growth is the increasing investments in clinical studies for pharmacokinetics and pharmacogenomics.

Global computational biology market report covers segmentation analysis of tools, services applications and end users. Report further covers segments of tools which includes databases, infrastructure (Hardware) and analysis software & services. Among these segments, databases segment had dominated the tools segment and had recorded a market revenue share of about 45% in 2015. This was due to the massive genomic database usage for data mining and warehousing of biological and sequential data which is generated from analysis of genomic and proteomic data. Moreover, the analysis software and services segment used for the analysis of biological data is the fastest growing segment with a CAGR of over 21% during the forecast period. Whereas, applications of computational biology include cellular & biological simulation, drug discovery and disease modeling, preclinical drug development, clinical trials and human body simulation software. The cellular simulation application is the fastest growing segment with a CAGR of over 22% due to the transition in sequencing studies towards detailed analysis of the characteristics of various biological proteins which is the part of development of customized medicine. Furthermore, drug discovery and disease modelling application segment had dominated the global computational biology market and had accounted for market share of 58.0% in terms of revenue share in 2015.  The key factor attributing to the growth of this segment is the large number of drug development pipelines which are currently deployed for several global leading generic drug manufacturing industries  such as Sanofi, Eli Lilly and Novo Nordisk.

The major market players of the global computational biology market are:

  • CERTARA
  • CHEMICAL COMPUTING GROUP INC.
  • COMPUGEN LTD.
  • GENEDATA AG
  • SIMULATION PLUS INC
  • OTHERS







 

These companies are using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, product and service launch is the key strategy adopted by the companies in the computational biology market.

For Example; In Jan 2017, Genedata AG launched Data Science Services which would offer on demand, project based assistance in data analysis and perception for the emerging field ofprecision medicines.

Similarly, in April 2017, Simulation plus launched the latest version of GastroPlus named as GastroPlus version 9.5. It is computational software consists of new features such as models for antibody drug conjugates etc. This would be used to provide assistance for process of drug approval.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in computational biology market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023
  • Report includes detailed analysis of different segments such astools, services applications and end users of computational biology.
  • Identify and understand the strength, opportunities, challenges and threat of the computational biology market.
  • Covers details analysis of Porters 5 force model and other strategic models and covers revenues, market share analysis and competitive landscape analysis of major players of computational biology market.
  • Detailed analysis of various the regulatory policies which are affecting the global computational biology market.






 

How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global computational biology market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the computational biology market, with giving extensive SCOT analysis of key companies. 

Key findings of the global computational biology market

  • The global computational biology market is anticipated to grow with a CAGR of around 21% during the forecast period 2016-2023.
  • North America has emerged as the largest market for computational biology market. Asia pacific is the fastest growing region and is anticipated to account for large computational biology market growth with a CAGR of around 29% during the forecasted period.
  • Databasessegment had dominated the tools segment and had recorded a market revenue share of about 45% in 2015. Drug discovery and disease modelling application segment had dominated the global computational biology market.
  • Product and service launch is the key strategy adopted by the companies in the computational biology market. 
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL COMPUTATIONAL BIOLOGY MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTER'S 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS AND TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INCREASING USAGE OF COMPUTATIONAL BIOLOGY
3.1.2. INCREASING NUMBER OF CLINICAL STUDIES IN PHARMACOGENOMICS AND PHARMACOKINETICS
3.1.3. LARGE APPLICATIONS FOR BIOINFORMATICS R&D PROGRAMS
3.1.4. GROWTH OF DRUG DESIGNING
3.2. MARKET RESTRAINTS
3.2.1. LACK OF STANDARDIZATION OF COMPUTATIONAL BIOLOGY TOOLS
3.3. MARKET OPPORTUNITIES
3.3.1. ADOPTION OF CLOUD COMPUTING IN COMPUTATIONAL BIOLOGY
3.3.2. USE OF MODELING AND SIMULATION
3.3.3. TECHNOLOGICAL ADVANCEMENT 
3.4.  MARKET CHALLENGES 
3.4.1. DATA STORAGE ISSUES
3.4.2. CONSTANT ADDITION OF NEW GENOMES INTO DATABASES
3.4.3. LACK OF SKILLED PROFESSIONALS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY TOOLS
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL DATABASE MARKET 
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL HARDWARE INFRASTRUCTURE MARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL ANALYSIS SOFTWARE AND SERVICES MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY SERVICES
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL IN-HOUSE COMPUTATIONAL BIOLOGY MARKET 
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. TOP PLAYERS & KEY PRODUCTS 
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL EXTERNAL/CONTRACT COMPUTATIONAL BIOLOGY MARKET 
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. TOP PLAYERS & KEY PRODUCTS 
4.2.5.2.4. KEY CONCLUSIONS
4.3. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY APPLICATIONS
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL CELLULAR AND BIOLOGICAL SIMULATION MARKET 
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. TOP PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL DRUG DISCOVERY AND DISEASE MODELLING MARKET 
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. TOP PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL PRECLINICAL DRUG DEVELOPMENT MARKET 
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. TOP PLAYERS & KEY PRODUCTS 
4.3.5.3.4. KEY CONCLUSIONS
4.3.5.4. GLOBAL CLINICAL TRIALS MARKET 
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3. TOP PLAYERS & KEY PRODUCTS 
4.3.5.4.4. KEY CONCLUSIONS
4.3.5.5. GLOBAL HUMAN BODY SIMULATION SOFTWARE  MARKET 
4.3.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.3. TOP PLAYERS & KEY PRODUCTS 
4.3.5.5.4. KEY CONCLUSIONS
4.4. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY END USER 
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL ACAMEDICS  MARKET 
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. TOP PLAYERS & KEY PRODUCTS 
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL  INDUSTRIAL  MARKET 
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. TOP PLAYERS & KEY PRODUCTS 
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL COMMERCIAL MARKET 
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. TOP PLAYERS & KEY PRODUCTS 
4.4.5.3.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. CERTARA (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. ACCELRYS  (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. CHEMICAL COMPUTING GROUP INC. (CANADA)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS 
7.3.6. STRATEGIC ANALYSIS
7.4. ENTELOS (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. COMPUGEN LTD.  (ISRAEL)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. INSILICO BIOTECHNOLOGY AG  (GERMANY)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS 
7.6.6. STRATEGIC ANALYSIS
7.7. GENEDATA AG (SWITZERLAND)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS 
7.7.6. STRATEGIC ANALYSIS
7.8. SANOFI PASTEUR (FRANCE)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS 
7.8.6. STRATEGIC ANALYSIS
7.9. ROCHE (SWITZERLAND)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS 
7.9.6. STRATEGIC ANALYSIS
7.10. NOVARTIS (SWITZERLAND)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS 
7.10.6. STRATEGIC ANALYSIS
7.11. PFIZER (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. SIMULATION PLUS INC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. SCHRODINGER LLC ( U.S.)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. LEADSCOPE INC.  ( U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. NIMBUS TECHNOLOGY  LLC ( U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
1. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY TOOLS  2014-2023 ($ MILLION)
2. GLOBAL DATABASE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL HARDWARE INFRASTRUCTURE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL ANALYSIS SOFTWARE AND SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY SERVICES 2014-2023 ($ MILLION)
6. GLOBAL IN-HOUSE COMPUTATIONAL BIOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL EXTERNAL/CONTRACT COMPUTATIONAL BIOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY APPLICATIONS 2014-2023 ($ MILLION)
9. GLOBAL CELLULAR AND BIOLOGICAL SIMULATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL DRUG DISCOVERY AND DISEASE MODELLING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL PRECLINICAL DRUG DEVELOPMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL CLINICAL TRIALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL HUMAN BODY SIMULATION SOFTWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL COMPUTATIONAL BIOLOGY MARKET BY END USER  2014-2023 ($ MILLION)
15. GLOBAL ACAMEDICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL INDUSTRIAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. GLOBAL COMMERCIAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. NORTH AMERICA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
19. EUROPE COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
20. ASIA PACIFIC COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
21. REST OF THE WORLD COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
1. GLOBAL COMPUTATIONAL BIOLOGY MARKET   2014-2023 ($ MILLION)
2. GLOBAL DATABASE MARKET  2014-2023 ($ MILLION)
3. GLOBAL HARDWARE INFRASTRUCTURE MARKET  2014-2023 ($ MILLION)
4. GLOBAL ANALYSIS SOFTWARE AND SERVICES MARKET  2014-2023 ($ MILLION)
5. GLOBAL IN-HOUSE COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
6. GLOBAL EXTERNAL/CONTRACT COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
7. GLOBAL CELLULAR AND BIOLOGICAL SIMULATION MARKET 2014-2023 ($ MILLION)
8. GLOBAL DRUG DISCOVERY AND DISEASE MODELLING MARKET 2014-2023 ($ MILLION)
9. GLOBAL PRECLINICAL DRUG DEVELOPMENT MARKET  2014-2023 ($ MILLION)
10. GLOBAL CLINICAL TRIALS MARKET  2014-2023 ($ MILLION)
11. GLOBAL HUMAN BODY SIMULATION SOFTWARE MARKET  2014-2023 ($ MILLION)
12. GLOBAL ACAMEDICS MARKET 2014-2023 ($ MILLION)
13. GLOBAL INDUSTRIAL MARKET  2014-2023 ($ MILLION)
14. GLOBAL COMMERCIAL MARKET  2014-2023 ($ MILLION)
15. UNITED STATES (U.S.)  COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
16. CANADA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
17. UNITED KINGDOM (UK) COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
18. FRANCE COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
19. GERMANY COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
20. SPAIN COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
21. ROE COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
22. INDIA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
23. CHINA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
24. JAPAN COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
25. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
26. ROAPAC COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
27. LATIN AMERICA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)
28. MENA COMPUTATIONAL BIOLOGY MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.